Population-Based Analysis of the Risk of Mycobacterial Infections Associated With Immune Checkpoint Inhibitors.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 39871728.
- Also identified by DOI 10.1093/cid/ciae626 and PMC identifier 12314488.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this population-based study, we examined the risk of nontuberculous mycobacterial disease associated with immune checkpoint inhibitors among people with cancer. Using a nested case-control design, we identified 184 cases and 714 matched controls; there was no significant association on conditional logistic regression (adjusted odds ratio, 0.51 [95% confidence interval, .17-1.50]; P = .22).
Medical subject headings
- Immune Checkpoint Inhibitors
- Neoplasms
- Mycobacterium Infections, Nontuberculous